- Home
- NVO vs WFC Comparison
NVO vs WFC Comparison
Compare NVO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | WFC |
|---|---|---|
| Founded | 1923 | 1852 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.6B | 290.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | WFC |
|---|---|---|
| Price | $49.23 | $86.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $54.25 | ★ $97.37 |
| AVG Volume (30 Days) | ★ 26.4M | 16.9M |
| Earning Date | 02-04-2026 | 01-14-2026 |
| Dividend Yield | ★ 2.48% | 2.07% |
| EPS Growth | 1.77 | ★ 16.57 |
| EPS | 3.62 | ★ 6.26 |
| Revenue | $48,588,245,669.00 | ★ $80,041,000,000.00 |
| Revenue This Year | $1.02 | $11.53 |
| Revenue Next Year | $6.81 | $4.57 |
| P/E Ratio | ★ $13.61 | $13.89 |
| Revenue Growth | ★ 6.43 | 2.67 |
| 52 Week Low | $43.08 | $58.42 |
| 52 Week High | $93.80 | $97.76 |
Technical Indicators
Market Signals| Indicator | NVO | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 36.28 |
| Support Level | $48.08 | $89.00 |
| Resistance Level | $50.07 | $95.09 |
| Average True Range (ATR) | 2.07 | 2.83 |
| MACD | -0.98 | -0.49 |
| Stochastic Oscillator | 31.96 | 5.10 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.